Crystal Structure of Human TWEAK in Complex with the Fab Fragment of a Neutralizing Antibody Reveals Insights into Receptor Binding

por Lammens, Alfred, Baehner, Monika, Kohnert, Ulrich, Niewoehner, Jens, von Proff, Leopold, Schraeml, Michael, Lammens, Katja, Hopfner, Karl-Peter
Publicado 2013

PK/PD Mediated Dose Optimization of Emactuzumab, a CSF1R Inhibitor, in Patients With Advanced Solid Tumors and Diffuse‐Type Tenosynovial Giant Cell Tumor

por Smart, Kevin, Bröske, Ann‐Marie, Rüttinger, Dominik, Mueller, Claudia, Phipps, Alex, Walz, Antje‐Christine, Ries, Carola, Baehner, Monika, Cannarile, Michael, Meneses‐Lorente, Georgina
Publicado 2020

Anti-tumoral, anti-angiogenic and anti-metastatic efficacy of a tetravalent bispecific antibody (TAvi6) targeting VEGF-A and angiopoietin-2

por Scheuer, Werner, Thomas, Markus, Hanke, Petra, Sam, Johannes, Osl, Franz, Weininger, Diana, Baehner, Monika, Seeber, Stefan, Kettenberger, Hubert, Schanzer, Jürgen, Brinkmann, Ulrich, Weidner, K. Michael, Regula, Jörg, Klein, Christian
Publicado 2016

Phase I clinical study of RG7356, an anti-CD44 humanized antibody, in patients with acute myeloid leukemia

por Vey, Norbert, Delaunay, Jacques, Martinelli, Giovanni, Fiedler, Walter, Raffoux, Emmanuel, Prebet, Thomas, Gomez-Roca, Carlos, Papayannidis, Cristina, Kebenko, Maxim, Paschka, Peter, Christen, Randolph, Guarin, Ernesto, Bröske, Ann-Marie, Baehner, Monika, Brewster, Michael, Walz, Antje-Christine, Michielin, Francesca, Runza, Valeria, Meresse, Valerie, Recher, Christian
Publicado 2016